Abstract
Objective
To evaluate the diagnostic accuracy of a multi-disease offline artificial intelligence system (Medios-AI, MAI), integrated into a smartphone-based fundus camera, for simultaneous screening of diabetic retinopathy (DR), glaucoma, and age-related macular degeneration (AMD) in a real-world setting.
Methods
In this prospective cross-sectional study, 193 adults (371 eyes) aged ≥18 years with DR, glaucoma, AMD, or normal fundus were enrolled between May and December 2024. Dilated fundus imaging was performed using the Remidio Fundus on Phone (FoP) and Zeiss Clarus 500 cameras. Ungradable images were excluded. The offline MAI algorithm generated disease-specific reports, which were compared to masked grading of Clarus images by two fellowship-trained ophthalmologists. In ambiguous cases, the AI report defaulted to “either DR or AMD.”
Results
MAI achieved sensitivity of 99.3% (95% CI: 96–100), specificity of 95.7% (95% CI: 92–98), and AUROC of 0.99 for detecting any retinal disease. For glaucoma (n = 109), sensitivity was 98.2% (95% CI: 94–100), specificity 99.0% (95% CI: 97–100), AUROC 0.99. For AMD (n = 56), sensitivity was 88.9% (95% CI: 77–96), specificity 97.5% (95% CI: 95–99), AUROC 0.93. For DR (n = 78), sensitivity was 84.6% (95% CI: 75–92), specificity 99.0% (95% CI: 97–100), AUROC 0.92. Agreement on vertical cup-to-disc ratio between AI and graders ranged from −0.1 to +0.1, with intergrader ICC of 0.97 (P < 0.001 for all comparisons).
Conclusions
MAI demonstrated significant diagnostic accuracy for DR, glaucoma, and AMD using an offline, smartphone-based platform, supporting scalable, point-of-care retinal screening in resource-limited settings.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
